chr3-98354007-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001005517.1(OR5K4):c.154G>A(p.Glu52Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000659 in 1,614,172 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005517.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5K4 | NM_001005517.1 | c.154G>A | p.Glu52Lys | missense_variant | 1/1 | ENST00000354924.2 | NP_001005517.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5K4 | ENST00000354924.2 | c.154G>A | p.Glu52Lys | missense_variant | 1/1 | 6 | NM_001005517.1 | ENSP00000347003.2 | ||
ENSG00000251088 | ENST00000508616.1 | n.188+11578G>A | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000756 AC: 190AN: 251240Hom.: 1 AF XY: 0.000788 AC XY: 107AN XY: 135784
GnomAD4 exome AF: 0.000679 AC: 992AN: 1461874Hom.: 2 Cov.: 32 AF XY: 0.000694 AC XY: 505AN XY: 727236
GnomAD4 genome AF: 0.000466 AC: 71AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.000483 AC XY: 36AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2021 | The c.154G>A (p.E52K) alteration is located in exon 1 (coding exon 1) of the OR5K4 gene. This alteration results from a G to A substitution at nucleotide position 154, causing the glutamic acid (E) at amino acid position 52 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at